Short Interest in Mayne Pharma Group Limited (OTCMKTS:MAYNF) Grows By 150.5%

Mayne Pharma Group Limited (OTCMKTS:MAYNF) was the recipient of a large increase in short interest during the month of May. As of May 15th, there was short interest totaling 162,560 shares, an increase of 150.5% from the April 30th total of 64,905 shares. Based on an average daily volume of 910 shares, the days-to-cover ratio is currently 178.6 days.

Mayne Pharma Group Stock Performance

MAYNF stock opened at $1.60 on Friday. The company has a fifty day moving average price of $1.68 and a 200 day moving average price of $2.01. Mayne Pharma Group has a 12 month low of $1.40 and a 12 month high of $4.00.

Mayne Pharma Group Company Profile

Mayne Pharma Group (OTCMKTS:MAYNF) is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of prescription products. The company’s portfolio spans oral, transdermal and topical dosage forms, with a particular emphasis on women’s health, dermatology, pain management and other niche therapeutic areas. Through both branded and generic offerings, Mayne Pharma seeks to address unmet patient needs and provide cost-effective alternatives to established treatments.

In its development operations, Mayne Pharma leverages a combination of in-house research and external partnerships to advance product candidates through regulatory review.